MedPath

The New York State Psychiatric Institute

The New York State Psychiatric Institute logo
🇺🇸United States
Ownership
Private
Established
1895-01-01
Employees
251
Market Cap
-
Website
http://www.nyspi.org

Facilitating Rapid Naltrexone Initiation

Phase 3
Active, not recruiting
Conditions
Opioid Dependence
Interventions
Drug: CI-581-a
Drug: CI-581-b
First Posted Date
2017-11-17
Last Posted Date
2024-02-02
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
100
Registration Number
NCT03345173
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders

Phase 3
Suspended
Conditions
Cocaine Use Disorder
Interventions
Behavioral: Motivational Enhancement Therapy (MET)
Behavioral: Mindfulness Based Relapse Prevention
First Posted Date
2017-11-17
Last Posted Date
2024-07-16
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
150
Registration Number
NCT03344419
Locations
🇺🇸

NYSPI, New York, New York, United States

Investigation of the NMDA Antagonist Ketamine as a Treatment for Tinnitus

Phase 2
Completed
Conditions
Tinnitus
Interventions
First Posted Date
2017-11-08
Last Posted Date
2024-07-03
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
42
Registration Number
NCT03336398
Locations
🇺🇸

1051 Riverside Drive, New York, New York, United States

Treating Hearing Loss to Improve Mood and Cognition in Older Adults

Phase 4
Completed
Conditions
Depression
Hearing Loss
Interventions
Device: Phonak Audeo B-R 90 hearing aid device (Active)
Device: Audeo B-R 90 hearing aid device (Sham)
First Posted Date
2017-10-25
Last Posted Date
2021-10-04
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
25
Registration Number
NCT03321006
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Glutamate Reducing Interventions in Schizophrenia

Phase 1
Completed
Conditions
Clinical High Risk for Psychosis
Interventions
First Posted Date
2017-10-25
Last Posted Date
2021-12-01
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
16
Registration Number
NCT03321617
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Evaluation of the Communities of Healing Mentorship/Support Group Program: Assessment of Preliminary Efficacy

Not Applicable
Completed
Conditions
Eating Disorder
Binge-Eating Disorder
Bulimia Nervosa
Anorexia Nervosa
Interventions
Behavioral: Peer mentorship
Behavioral: Social support mentorship
Behavioral: Recovery Record use with mentor
First Posted Date
2017-10-23
Last Posted Date
2021-08-19
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
60
Registration Number
NCT03317379
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Add-on to Cognitive, Event-Related Potentials (ERP) and Electroencephalogram (EEG) Asymmetry in Affective Disorders

Phase 4
Withdrawn
Conditions
Depressive Illness
Interventions
First Posted Date
2017-09-12
Last Posted Date
2019-03-15
Lead Sponsor
New York State Psychiatric Institute
Registration Number
NCT03278938
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Effects of Marijuana on Symptoms of OCD

Phase 1
Completed
Conditions
Obsessive-Compulsive Disorder
Interventions
Other: Placebo
First Posted Date
2017-09-07
Last Posted Date
2020-11-18
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
14
Registration Number
NCT03274440
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Pregabalin as Treatment for Alcohol Use Disorder

Phase 2
Completed
Conditions
Alcohol Use Disorder
Interventions
First Posted Date
2017-08-21
Last Posted Date
2020-08-31
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
18
Registration Number
NCT03256253
Locations
🇺🇸

Columbia Univeristy-STARS, New York, New York, United States

Effect of Lorcaserin on Cannabis Withdrawal and Self-administration

Phase 1
Completed
Conditions
Cannabis Use
Interventions
First Posted Date
2017-08-18
Last Posted Date
2022-07-26
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
15
Registration Number
NCT03253926
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath